glp-1 sglt2 Blood Pressure-Lowering Effects of Inhibitors and Receptor Agonists | Current Hypertension Reports SGLT2 Inhibitors and GLP-1 Receptor

It is not intended as a substitute for professional medical advice, diagnosis, or treatment

March 16, 2023 AMA #45: Pros And Cons Of GLP-1 Weight Loss Drugs And Metformin As Geroprotective Agent | The Drive with Peter Attia #246 Check out The Drive episode page Key Takeaways GLP-1 and GIP both started as drugs to control glucose and insulin resistance in people developing or with type 2 diabetes Studies showed the added benefit of GLP-1 agonists on weight loss but the mechanism is unclear, though they do reduce appetite in some way Introduction In this special episode of The Drive, Peter focuses the discussion on two topics getting a lot of attention recently: GLP-1 agonists for weight loss and metformin for longevity

ABSTRACT Background Cirrhosis is characterized by complications, including hepatic encephalopathy (HE), hepatorenal syndrome (HRS), and acute variceal bleeding, Glucagon-like peptide1 (GLP1) analogs, have shown potential benefits in reducing liver inflammation and lowering cirrhosis-related complications

Pre-clinical evaluation of a modified cyclodextrin-based nanoparticle for intestinal delivery of liraglutide

Health-conscious individuals concerned about metabolic health, those with family histories of diabetes or cardiovascular disease, and patients experiencing unexplained fatigue, weight changes, or vision problems should consider this screening (Epicentre 2025)